Chronic HCV infection affects approximately 2% of the US population. An improved understanding of virus-host interactions and the factors leading to viral clearance are essential in the development of improved therapies. This proposal directly addresses these needs. The first specific aim is to employ HCV replicon systems to define the requirements for a permissive host environment for replication. The hypothesis of this section is that a specific cellular environment is required for HCV RNA replication and that identification and utilization of cells with different capacities for replication provides a mechanism to approach the definition of factors that influence replication. The host-virus interaction will be explored through the use of a variety species of primary hepatocytes and livered derived cell lines. Gene array technology will be employed to define genes that positively or negatively regulate HCV RNA replication. The second specific aim is to utilize gene array technology to examine chimpanzee liver tissues at various stages of HCV infection to define changes in liver gene expression. The hypothesis of this aim is that specific alterations in liver gene expression will accompany different defined stages of infection with HCV. Changes will represent direct alterations in the hepatocyte due to interaction with HCV gene products; alterations in hepatocyte gene expression in response to the inflammatory response; and alterations in immune response genes will occur and change as the infection progresses. The later changes may be predictive of whether the infection results in viral clearance or persistence. The third specific aim is to defined factors relate to viral clearance. The emphasis will be the evaluation of cytokine and chemokine mRNA profiles in the liver of chimpanzees during well-defined phases of infection. The hypothesis is that specific cytokine profiles will be predictive of whether the animal clears HCV. We will utilize quantitative RT-PCR and a specialized gene array for cytokines, chemokines and their receptors. This approach will provide a more holistic picture of the immune response to HCV infection and the type of response associated with viral clearance. Cytokines that are candidates for potentially modulating HCV replication will be tested for antiviral activity.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
2U19AI040035-05
Application #
6405158
Study Section
Special Emphasis Panel (ZAI1)
Project Start
1996-08-01
Project End
2005-07-31
Budget Start
Budget End
Support Year
5
Fiscal Year
2000
Total Cost
Indirect Cost
Name
University of Texas Medical Br Galveston
Department
Type
DUNS #
041367053
City
Galveston
State
TX
Country
United States
Zip Code
77555
Jarret, Abigail; McFarland, Adelle P; Horner, Stacy M et al. (2016) Hepatitis-C-virus-induced microRNAs dampen interferon-mediated antiviral signaling. Nat Med 22:1475-1481
Hong, MeeAe; Schwerk, Johannes; Lim, Chrissie et al. (2016) Interferon lambda 4 expression is suppressed by the host during viral infection. J Exp Med 213:2539-2552
Yi, MinKyung; Hu, Fengyu; Joyce, Michael et al. (2014) Evolution of a cell culture-derived genotype 1a hepatitis C virus (H77S.2) during persistent infection with chronic hepatitis in a chimpanzee. J Virol 88:3678-94
Li, Kui; Lemon, Stanley M (2013) Innate immune responses in hepatitis C virus infection. Semin Immunopathol 35:53-72
Wilkins, Courtney; Woodward, Jessica; Lau, Daryl T-Y et al. (2013) IFITM1 is a tight junction protein that inhibits hepatitis C virus entry. Hepatology 57:461-9
Horner, Stacy M; Park, Hae Soo; Gale Jr, Michael (2012) Control of innate immune signaling and membrane targeting by the Hepatitis C virus NS3/4A protease are governed by the NS3 helix ?0. J Virol 86:3112-20
Welsch, Christoph; Schweizer, Sabine; Shimakami, Tetsuro et al. (2012) Ketoamide resistance and hepatitis C virus fitness in val55 variants of the NS3 serine protease. Antimicrob Agents Chemother 56:1907-15
Zhou, Yan; Callendret, BenoƮt; Xu, Dan et al. (2012) Dominance of the CD4(+) T helper cell response during acute resolving hepatitis A virus infection. J Exp Med 209:1481-92
Grebely, Jason; Prins, Maria; Hellard, Margaret et al. (2012) Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine. Lancet Infect Dis 12:408-14
Shimakami, Tetsuro; Yamane, Daisuke; Jangra, Rohit K et al. (2012) Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex. Proc Natl Acad Sci U S A 109:941-6

Showing the most recent 10 out of 156 publications